Flex Pharma Inc.

Flex Pharma Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.88
Market Cap
$9.63 M
Shares Outstanding
18.07 M
Public Float
14.25 M

Profile

Address
31 St. James Avenue
Boston Massachusetts 02116
United States
Employees -
Website http://www.flex-pharma.com
Updated 07/08/2019
Flex Pharma, Inc. operates as a biotechnology company. It engages in developing treatments for exercise-associated muscle cramps, nocturnal leg cramps and spasms associated with severe neuromuscular conditions. The company operates through the following business segments: Consumer Operations and Drug Development.

Financials

View All
Created with Highcharts 5.0.14Flex Pharma Inc.Net Income. Fiscal year is January-December. All values USD Thousands.8 0108 01029 14129 14139 49339 49334 43334 43321 92221 92220142015201620172018010k20k30k40k50k
Created with Highcharts 5.0.14Flex Pharma Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.00001 0101 0101 2741 274838838201420152016201720180250500750100012501500

William K. McVicar
President, Chief Executive Officer & Director
Roger D. Tung
Independent Director